Bio-Techne (TECH) Net Income towards Common Stockholders (2009 - 2026)

Bio-Techne's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 125.99% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $22.7 million (down 71.78% YoY), while the FY2025 annual figure was -$13.4 million, down 111.46% from the prior year.
• Net Income towards Common Stockholders was $51.0 million for Q1 2026 at Bio-Techne, up from $38.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $89.7 million in Q3 2022 to a low of -$104.5 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged $35.8 million across 5 years, with a median of $45.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders soared 193.98% in 2022, then tumbled 899.35% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $50.0 million in 2022, then sank by 45.08% to $27.5 million in 2023, then advanced by 27.03% to $34.9 million in 2024, then advanced by 8.94% to $38.0 million in 2025, then jumped by 34.3% to $51.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $51.0 million (Q1 2026), $38.0 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.